If you are a cardiovascular health tech manufacturer dealing with the lack of continuous blood pressure monitoring outside hospitals — this project developed a shape-memory polymer sensor that allows for minimally invasive implantation and long-term tracking.
Implantable Smart Sensors for Continuous Blood and Internal Body Pressure Monitoring
Imagine a tiny sensor that can be rolled up like a scroll to fit through a small needle. Once inside the body, it uses body heat to unfold and hug an artery to take measurements. It then sends that data wirelessly to a watch on your wrist, removing the need for bulky arm cuffs.
What needed solving
There is no clinically accepted method for continuous blood pressure monitoring outside of hospitals, leaving a massive gap in treating high-risk patients.
What was built
A minimally invasive implantable microsensor system using a temperature-dependent shape memory polymer and a wrist-worn reader.
Who needs this
Who can put this to work
If you are a specialized eye-care device developer dealing with the need for precise intraocular pressure tracking — this project developed a disruptive sensor that can be adapted for non-arterial pressure use cases.
If you are a neuro-monitoring equipment provider dealing with the difficulty of monitoring intracranial pressure — this project developed a biocompatible microsensor that can be delivered minimally invasively to target tissues.
Quick answers
What is the cost or price of the sensor?
Based on available project data, specific unit costs or pricing models are not provided.
Can this be produced at an industrial scale?
The project explicitly addresses quality and manufacturing aspects to prepare the sensor for the market.
Is the technology protected by IP or available for licensing?
The consortium has already developed and IP-protected the disruptive sensor technology.
What regulatory hurdles are being addressed?
The project is delivering a regulatory strategy and performing validation for biocompatibility, safety, and longevity.
What is the timeline for market entry?
The project runs from 2022-12-01 to 2026-11-30, focusing on preclinical studies and regulatory strategies before market delivery.
Who built it
The project is highly commercially oriented, with a 75% industry ratio consisting of 6 industrial partners, 4 of which are SMEs. This strong industrial presence, combined with 2 universities across 6 countries, suggests a direct pipeline from research to commercial product development.
Contact the University of Galway for IP licensing and partnership inquiries.
Talk to the team behind this work.
Contact us to connect with the SMARTSHAPE consortium for early adoption opportunities.